Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Thursday, June 18, 2026 1 min read

Key Takeaway: Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Full Press Release Details

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).